ArticleCell death & disease2026

TSC22D4 drives clear cell renal cell carcinoma progression and therapy resistance by stabilizing NRF2 through KEAP1 disruption.

Bohan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.